Loading market dashboard
Mushrooms Inc
MSRMConsumer DefensiveOTCUS
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
Early validation of mycelium-based infection detection and AI-powered MycoLab.ai platform strengthens commercialization outlook and strategic flexibility ESTERO, Fla., March 24, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Mushrooms Inc.
ESTERO, Fla., March 24, 2026 (GLOBE NEWSWIRE) -- Mushrooms Inc. (OTC: MSRM) today announced the successful early-stage validation of its mycelium-based infection detection technology and the completion of beta testing for its MycoLab.ai research platform, marking a significant advancement in the development of its MycoLabX platform.
